Evaxion Biotech A/S financial data

Symbol
EVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Dr Neergaards Vej 5 F, Hoersholm, Denmark
State of incorporation
Denmark
Fiscal year end
December 31
Latest financial report
Q4 2023 - Mar 26, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.9 M shares +57%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 11.9 M USD -30.1%
General And Administrative Expense 10.4 M USD +26.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 12.9 M USD -41.5%
Liabilities 17.6 M USD +28.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense 1 K USD -97.1%